Jasper Therapeutics Announces Merger with Kira Pharmaceuticals
Jasper Therapeutics has completed the acquisition of Kira Pharmaceuticals in an all-stock merger, creating a combined company focused on advancing innovative biologic therapies targeting immunologically-driven disorders. Concurrently, Jasper raised $132 million in private financing to support development through the second half of 2028. The expande…